| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 73,280 | |||
| Prepaid expenses and other assets | 486 | |||
| Research and development (r&d) tax incentive receivable | 4,529 | |||
| Total current assets | 78,295 | |||
| Property, plant and equipment, net | 168 | |||
| Investment in joint venture | 45 | |||
| Operating lease right-of-use assets | 212 | |||
| Total assets | 78,720 | |||
| Trade and other payables | 1,296 | |||
| Accrued expenses and other current liabilities | 206 | |||
| Operating lease liabilities, current | 146 | |||
| Total current liabilities | 1,648 | |||
| Operating lease liabilities, non-current | 64 | |||
| Total liabilities | 1,712 | |||
| Common stock, 0.0001 par value shares 800,000,000 authorized 347,705,507 and 194,379,996 shares issued and outstanding at september 30, 2025 and june 30, 2025 respectively | 35 | |||
| Additional paid-in capital | 243,837 | |||
| Accumulated deficit | -163,963 | |||
| Foreign currency translation reserve | -2,901 | |||
| Total stockholders equity | 77,008 | |||
| Total liabilities and stockholders equity | 78,720 | |||
Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc. (IXHL)